News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Ann Culkin, RN, OCN

Advertisement

Articles by Ann Culkin, RN, OCN

Ann Culkin on Helping Patients Interpret Information Exchanged Online

ByAnn Culkin, RN, OCN
December 2nd 2016

Ann Culkin discusses how to help patients interpret and understand information they receive from the internet.

Advertisement

Latest Updated Articles

  • Ann Culkin on Helping Patients Interpret Information Exchanged Online
    Ann Culkin on Helping Patients Interpret Information Exchanged Online

    Published: December 2nd 2016 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Opinion: CAR T-Cell Therapy Shows Promise in Gastric and GEJ Cancers

2

Real, Placebo Acupuncture Improve Cognitive Outcomes in Breast Cancer Survivors

3

Maintenance Tucatinib/HP Improves PFS Post 2-Year Mark in HER2+ mBC

4

T-DXd/Pertuzumab Combo Earns FDA Approval in Advanced HER2+ Breast Cancer

5

FDA OKs Subcutaneous Amivantamab Across All NSCLC Indications

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us